AYA STEPS RCT: AYA Self-Management Via Texting, Education & Plans for Survivors

Adolescent and Young Adult (AYA) Cancer Survivors Clinical Trial

Official title:

AYA STEPS RCT: AYA Self-Management Via Texting, Education & Plans for Survivors

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT03363711
• Other study ID #: UPCC 26916
• Status: Active, not recruiting
• Start date: March 1, 2017
• Est. completion date: December 1, 2024

Study information

• Verified date: January 2024
• Source: Abramson Cancer Center at Penn Medicine
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The proposed project will leverage two programs of research at UPenn and CHOP that are delivering technology-based interventions to adolescent and young adult (AYA) cancer survivors.

In the proposed study, all AYA survivors will receive a care plan via a tool (Smart-ALACC). They will then be randomized to receive (or not) a mobile health application (AYA STEPS) that will provide tailored messages to enhance uptake of their care plan.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 25
• Est. completion date: December 1, 2024
• Est. primary completion date: December 1, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 15 Years to 29 Years

Eligibility

Inclusion Criteria:

• AYA is 15-29 year old with a history of a malignant cancer diagnosis;

• Completed cancer treatment and are currently in remission or receiving cancer survivorship care;

• Seen for follow-up oncology care at CHOP or Penn;

• For AYA less than 18 years old, must have a caregiver to provide informed consent.

Exclusion Criteria:

• Cognitive impairments that would limit AYA ability to independently care for health as determined by the medical team.

• Absence of the inclusion criteria

Related Conditions & MeSH terms

• Adolescent and Young Adult (AYA) Cancer Survivors

Intervention

Other:
• AYA STEPS
a mobile health application

Locations

Country	Name	City	State
United States	Abramson Cancer Center of the University of Pennsylvania	Philadelphia	Pennsylvania

Sponsors (1)

Lead Sponsor	Collaborator
Abramson Cancer Center at Penn Medicine

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of Completed mobile data and questionnaires		10 years